drugset / Trial / NCT00605033
A Randomized Acceptability and Safety Study of the Transfer From Subutex to Suboxone in Opioid- Dependent Subjects (Study P04843)(COMPLETED)
RandomizedParallel-groupTriple-blindTreatment
Summary
Post-marketing commitment to the European Medicines Agency to conduct a prospective, controlled study of the transfer from Subutex to Suboxone.
Timeline
- Start
- 2008-03
- Primary completion
- 2009-04
- Completion
- 2009-05
Drugs
| Evaluation | Drug | Modality | Dose | Route |
|---|---|---|---|---|
| Comparator | Buprenorphine | Other / unclassified | 4 mg | Subcutaneous |
| Comparator | Buprenorphine | Other / unclassified | 24 mg | Subcutaneous |
| Comparator | Naloxone | Small molecule | 1 mg | Subcutaneous |
| Comparator | Naloxone | Small molecule | 6 mg | Subcutaneous |